REBECA trial: a new piece of the evidence for bevacizumab in platinum-resistant recurrent ovarian cancer

por Lavacchi, Daniele, Fancelli, Sara, Gatta Michelet, Marta Rita, Catalano, Martina, Roviello, Giandomenico
Publicado 2020

KRAS G12 isoforms exert influence over up-front treatments: A retrospective, multicenter, Italian analysis of the impact of first-line immune checkpoint inhibitors in an NSCLC real...

por Fancelli, Sara, Caliman, Enrico, Mazzoni, Francesca, Paglialunga, Luca, Gatta Michelet, Marta Rita, Lavacchi, Daniele, Berardi, Rossana, Mentrasti, Giulia, Metro, Giulio, Birocchi, Ilaria, Delmonte, Angelo, Priano, Ilaria, Comin, Camilla Eva, Castiglione, Francesca, Bartoli, Caterina, Voltolini, Luca, Pillozzi, Serena, Antonuzzo, Lorenzo
Publicado 2022